SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending following news of Elon Musk's $1 billion stock purchase, signaling confidence in the company's future and sparking a rally among investors. The community is debating whether this is a long-term bullish signal or a short-term pump, with some focusing on the company's potential in robotics and AI, while others point to ongoing concerns about valuation and market competition.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is trending as community members highlight its strong community, real-world applications, and growing holder count. The community emphasizes a 'we don't gamble, we work' ethos, with community-led initiatives and real-world products like Kendu Energy driving excitement. Discussions also focus on positive distribution metrics and anticipation for the next alt-season.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as investors anticipate a potential rate cut decision from the Federal Reserve, while some traders express concerns about overvaluation and a possible "sell the news" event. Community chatter revolves around the sustainability of the current rally, with discussions about market mechanics, potential pullbacks, and the impact of the Fed's actions, as well as signs that insiders are selling.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle ($ORCL) is trending amid speculation around its involvement in a potential TikTok deal, with community members discussing the likelihood and potential impact of such an acquisition. Some traders believe positive news could send the stock soaring, while others express skepticism about the deal's value and sustainability, pointing to concerns about a possible "pump and dump" scenario. The stock's recent volatility, following a significant post-earnings surge, is also fueling debate about its near-term direction.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid discussions about the recent death of Charlie Kirk and its implications, sparking debates about political violence and ideological divides. Community members are sharing conflicting narratives surrounding the circumstances and motivations behind the event, with some linking it to broader cultural and political issues. The stock is also seeing general market discussion around potential rate cuts and broader economic conditions.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending amid retail interest possibly sparked by a congressional disclosure of stock purchases and speculation around future government contracts, drawing comparisons to Palantir ($PLTR). Bullish investors are actively analyzing chart patterns, anticipating a short squeeze, and expressing optimism about the company's AI-driven solutions within the growing AI for defense and security sector.

Nukkleus, Inc. is a financial technology company, which engages in the provision of blockchain-enabled technology solutions. It also offers software and technology solutions for worldwide crypto and foreign exchange transactions with a focus on the movement of funds via crypto rails and back-to-back access to fiat conversion in a compliant regulated fashion. It operates through the following geographical segments: United States, United Kingdom, and Malta. The company was founded on May 24, 2019 and is headquartered in New York, NY.

Nukkleus Inc - Ordinary Shares - New

Nukkleus Inc

Nukkleus Inc. is trending due to the withdrawal of a planned share offering, sparking speculation of a potential merger or acquisition and a possible short squeeze, especially with a relatively low float. The community is actively discussing price targets and the potential for significant upward movement, fueled by the reduced risk of dilution. Some traders believe the stock may experience halts and a parabolic run, while others are focused on technical levels and potential breakout points.

Slopana

$SLOPANA.X is gaining traction as the self-proclaimed 'king of digital slop,' capitalizing on the meme coin frenzy within the Solana ecosystem. Community members highlight its strong community, CTO leadership and are actively encouraging others to join before a potential surge, referencing its availability on Phantom Wallet.

Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics ($GLUE) is trending due to a $5.7 billion deal with Novartis for immune-mediated disease drugs, sparking excitement among investors. The community is discussing the potential for a short squeeze and comparing it to other recent high-flying stocks. Bullish sentiment is fueled by the significant upfront payment and future milestone potential, although some traders remain cautious.

Welcome to Auklora  Dive into the ultimate crypto penguin metaverse! Play, earn, and explore in our cozy Solana-powered world.  Earn $AUK Tokens  Collect coins while playing Auklora and convert them to $AUK tokens. Use our calculator to see how many tokens you can earn!  Create your unique penguin avatar with hundreds of clothing items, accessories, and special effects. Stand out in the crowd!  Explore the beautiful world of Auklora through these stunning screenshots from our community

Auklora

Auklora ($AUK.X) is trending as the community highlights its potential as a "Phantom gem," focusing on accumulation. The project's association with the Phantom chain is sparking interest and driving conversation among investors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator

Foundation Medicine, Inc. and PMV Pharmaceuticals, Inc. (NASDAQ: PMVP; PMV Pharma) today announced a partnership to develop Foundation Medicines tissue-based comprehensive genomic profiling test...

PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors

Rezatapopt is a first-in-class precision oncology investigational therapy for patients with advanced solid tumors with a TP53 Y220C mutation and KRAS wild-type (WT)First patient dosed in Phase 2...

PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women's Cancer

Phase 1 analysis from the PYNNACLE Phase 1/2 study showed promising efficacy of rezatapopt (PC14586) in heavily pre-treated patients with advanced ovarian cancer harboring a TP53 Y220C mutation...

PEAK6 Investments LLC Invests $200,000 in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)

PEAK6 Investments LLC purchased a new position in shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP  Free Report) during the third quarter, Holdings Channel.com reports. The fund purchased...

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares Purchased by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. increased its position in shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP  Free Report) by 3.5% during the third quarter, according to the...

PMV Pharmaceuticals reports FY results

PMV Pharmaceuticals reports FY results...

PMV Pharmaceuticals Inc (PMVP) Reports Full Year 2023 Financial Results

Strategic Focus on Rezatapopt Advances as Company Extends Cash RunwayRelated Stocks: PMVP...

PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights

Registrational, tumor-agnostic Phase 2 portion of PYNNACLE clinical trial of rezatapopt (PC14586), a first-in-class precision oncology investigational therapy in patients with advanced solid tumors...

PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference

PRINCETON, N.J., Feb. 26, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...

Principal Financial Group Inc. Decreases Stock Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)

Principal Financial Group Inc. lowered its position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP  Free Report) by 0.8% in the 3rd quarter, HoldingsChannel reports. The institutional investor...

PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.

PMV Pharmaceuticals Inc

Cut 25 bps

Cut 50+ bps

No change

Hike 25 bps

It’s Fed Decision Week. Polymarket gives a 90% chance of a 25 bps cut. What’s your call? 
 
*Powered by Polymarket

Current Price	$1.14
Prev Close	$1.23
Open	$1.21
Dividend Yield	0.00%
50-Day Moving Average	$1.41
Beta	1.09
Avg. Volume	344,223.57
PE Ratio	-0.79

52-Week High	$1.84
52-Week Low	$0.81
Market Capitalization	$65.18M
EPS (Annual)	-$1.14
Price to Book	0.46
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

PMVP
PMV Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PMVP News

PMVP PMV Pharmaceuticals Inc